
OSSDF
Healthcare · Medical Devices · $65.6M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 24, 2022 | Before the open | -0.42 | -0.40 | +4.8% |
| Feb 22, 2022 | Before the open | — | -0.06 | — |
| Nov 17, 2021 | Before the open | — | -0.03 | — |
| Aug 18, 2021 | Before the open | — | -0.03 | — |
| Apr 19, 2021 | Before the open | — | -0.05 | — |
| Feb 11, 2021 | Before the open | 0.00 | -0.83 | — |
| Nov 3, 2020 | After the close | 0.00 | -0.13 | — |
| Aug 19, 2020 | Before the open | 0.00 | -0.12 | — |
| May 13, 2020 | Before the open | 0.00 | -0.14 | — |
| Feb 13, 2020 | Before the open | 0.00 | -0.10 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.17 | — |
| Sep 30, 2019 | Time not confirmed | 0.00 | -0.11 | — |
| Jun 30, 2019 | Time not confirmed | 0.00 | -0.14 | — |
| Mar 31, 2019 |
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities…
| Time not confirmed |
| 0.00 |
| -0.16 |
| — |
| Dec 31, 2018 | Time not confirmed | 0.00 | -0.32 | — |
| Sep 30, 2018 | Time not confirmed | 0.00 | -0.33 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.34 | — |